Peter ten Dijke
Peter ten Dijke
Unknown affiliation
Verified email at
Cited by
Cited by
TGF-β signalling from cell membrane to nucleus through SMAD proteins
CH Heldin, K Miyazono, P Ten Dijke
Nature 390 (6659), 465-471, 1997
Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
H Ichijo, E Nishida, K Irie, P Dijke, M Saitoh, T Moriguchi, M Takagi, ...
Science 275 (5296), 90-94, 1997
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
A Nakao, M Afrakhte, A Morn, T Nakayama, JL Christian, R Heuchel, ...
Nature 389 (6651), 631-635, 1997
Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
S Dennler, S Itoh, D Vivien, P ten Dijke, S Huet, JM Gauthier
The EMBO journal 17 (11), 3091-3100, 1998
New insights into TGF-β–Smad signalling
P ten Dijke, CS Hill
Trends in biochemical sciences 29 (5), 265-273, 2004
Balancing the activation state of the endothelium via two distinct TGF-β type I receptors
MJ Goumans, G Valdimarsdottir, S Itoh, A Rosendahl, P Sideras, ...
The EMBO journal 21 (7), 1743-1753, 2002
TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4
A Nakao, T Imamura, S Souchelnytskyi, M Kawabata, A Ishisaki, E Oeda, ...
The EMBO journal 16 (17), 5353-5362, 1997
Specificity, diversity, and regulation in TGF‐β superfamily signaling
The FASEB Journal 13 (15), 2105-2124, 1999
Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis
SP Oh, T Seki, KA Goss, T Imamura, Y Yi, PK Donahoe, L Li, K Miyazono, ...
Proceedings of the National Academy of Sciences 97 (6), 2626-2631, 2000
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL Van Bezooijen, BAJ Roelen, A Visser, L Van Der Wee-pals, E De Wilt, ...
The Journal of experimental medicine 199 (6), 805-814, 2004
TGF-β signaling by Smad proteins
K Miyazono
Cytokine & growth factor reviews 11 (1-2), 15-22, 2000
Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter
O Korchynskyi, P Ten Dijke
Journal of Biological Chemistry 277 (7), 4883-4891, 2002
Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor
P Franzen, P ten Dijke, H Ichijo, H Yamashita, P Schulz, CH Heldin, ...
Cell 75 (4), 681-692, 1993
Extracellular control of TGFβ signalling in vascular development and disease
P Ten Dijke, HM Arthur
Nature reviews Molecular cell biology 8 (11), 857-869, 2007
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.
P Ten Dijke, H Yamashita, TK Sampath, AH Reddi, M Estevez, DL Riddle, ...
Journal of Biological Chemistry 269 (25), 16985-16988, 1994
Transforming growth factor-β1 to the bone
K Janssens, P Ten Dijke, S Janssens, W Van Hul
Endocrine reviews 26 (6), 743-774, 2005
Signaling of transforming growth factor‐β family members through Smad proteins
S Itoh, F Itoh, MJ Goumans, P ten Dijke
European Journal of Biochemistry 267 (24), 6954-6967, 2000
Activin receptor-like kinase (ALK) 1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling
MJ Goumans, G Valdimarsdottir, S Itoh, F Lebrin, J Larsson, C Mummery, ...
Molecular cell 12 (4), 817-828, 2003
Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction
F Lebrin, MJ Goumans, L Jonker, RLC Carvalho, G Valdimarsdottir, ...
The EMBO journal 23 (20), 4018-4028, 2004
Apoptosis in podocytes induced by TGF-β and Smad7
M Schiffer, M Bitzer, ISD Roberts, JB Kopp, P ten Dijke, P Mundel, ...
The Journal of clinical investigation 108 (6), 807-816, 2001
The system can't perform the operation now. Try again later.
Articles 1–20